Allspring Global Investments Holdings LLC Makes New $298,000 Investment in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA)

Allspring Global Investments Holdings LLC bought a new position in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 17,022 shares of the real estate investment trust’s stock, valued at approximately $298,000.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the company. Harbor Capital Advisors Inc. grew its stake in shares of Sabra Healthcare REIT by 17.2% during the 1st quarter. Harbor Capital Advisors Inc. now owns 4,377 shares of the real estate investment trust’s stock valued at $76,000 after buying an additional 642 shares during the period. Assetmark Inc. grew its stake in shares of Sabra Healthcare REIT by 33.4% during the 4th quarter. Assetmark Inc. now owns 2,618 shares of the real estate investment trust’s stock valued at $45,000 after buying an additional 656 shares during the period. Focus Partners Wealth grew its stake in shares of Sabra Healthcare REIT by 4.0% during the 4th quarter. Focus Partners Wealth now owns 20,771 shares of the real estate investment trust’s stock valued at $360,000 after buying an additional 797 shares during the period. QRG Capital Management Inc. grew its stake in shares of Sabra Healthcare REIT by 1.4% during the 1st quarter. QRG Capital Management Inc. now owns 60,796 shares of the real estate investment trust’s stock valued at $1,062,000 after buying an additional 813 shares during the period. Finally, Cambridge Investment Research Advisors Inc. grew its stake in shares of Sabra Healthcare REIT by 4.7% during the 1st quarter. Cambridge Investment Research Advisors Inc. now owns 18,921 shares of the real estate investment trust’s stock valued at $331,000 after buying an additional 853 shares during the period. 99.40% of the stock is owned by hedge funds and other institutional investors.

Sabra Healthcare REIT Stock Up 0.5%

Shares of Sabra Healthcare REIT stock opened at $18.46 on Friday. The company has a fifty day moving average price of $18.00 and a 200 day moving average price of $17.37. The company has a current ratio of 4.22, a quick ratio of 4.22 and a debt-to-equity ratio of 0.89. Sabra Healthcare REIT, Inc. has a twelve month low of $15.60 and a twelve month high of $20.03. The stock has a market cap of $4.39 billion, a price-to-earnings ratio of 31.29, a price-to-earnings-growth ratio of 1.52 and a beta of 0.85.

Sabra Healthcare REIT (NASDAQ:SBRA) last issued its quarterly earnings data on Monday, May 5th. The real estate investment trust reported $0.37 EPS for the quarter, topping analysts’ consensus estimates of $0.36 by $0.01. The firm had revenue of $183.54 million for the quarter, compared to analyst estimates of $180.23 million. Sabra Healthcare REIT had a net margin of 19.55% and a return on equity of 5.14%. The firm’s revenue was up 10.1% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.35 EPS. Equities research analysts forecast that Sabra Healthcare REIT, Inc. will post 1.45 earnings per share for the current fiscal year.

Sabra Healthcare REIT Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, May 30th. Shareholders of record on Friday, May 16th were given a $0.30 dividend. The ex-dividend date of this dividend was Friday, May 16th. This represents a $1.20 dividend on an annualized basis and a yield of 6.50%. Sabra Healthcare REIT’s payout ratio is currently 203.39%.

Wall Street Analyst Weigh In

SBRA has been the subject of a number of research reports. Truist Financial upped their price target on shares of Sabra Healthcare REIT from $17.00 to $18.00 and gave the stock a “hold” rating in a research report on Tuesday, March 18th. Scotiabank upped their price target on shares of Sabra Healthcare REIT from $19.00 to $20.00 and gave the stock a “sector perform” rating in a research report on Monday, June 23rd. Three investment analysts have rated the stock with a hold rating, three have issued a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, Sabra Healthcare REIT presently has a consensus rating of “Moderate Buy” and a consensus target price of $19.67.

Insiders Place Their Bets

In other Sabra Healthcare REIT news, Director Michael J. Foster sold 11,000 shares of the company’s stock in a transaction dated Tuesday, May 20th. The shares were sold at an average price of $18.22, for a total value of $200,420.00. Following the completion of the transaction, the director directly owned 64,725 shares of the company’s stock, valued at $1,179,289.50. This represents a 14.53% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. 1.20% of the stock is currently owned by insiders.

About Sabra Healthcare REIT

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.